Paradigm’s Post

Our leadership team is in Israel today announcing a groundbreaking partnership with Sheba Medical Center, Tel Hashomer and ARC Innovation. We are honored to be part of this announcement highlighting Sheba’s ongoing leadership in #clinicaltrials and the role Paradigm will play in supporting the scaling of clinical trials throughout Israel, and the development of a global clinical trials network with Sheba and ARC. Sheba Medical Center is Israel's largest hospital and a well-established leader in clinical trials. Through the deployment of our platform, we will help extend Sheba’s reach, efficiency, and capabilities across Sheba and their affiliated clinics. We’ll be collaborating to streamline trial operations, including feasibility assessments, patient screening, recruitment, and data collection. Sheba is a hugely in-demand location for biopharma trials, and our work together will expand their capacity by lowering the administrative burden of trials. That means more patients will have access to innovative treatments, and providers will be able to spend more time focusing on patient care rather than paperwork. We're grateful for the trust of ARC Innovation and Sheba Medical Center, and honored to help serve their patients. From Israel to Japan to North Dakota and beyond, we're building a new, end-to-end clinical trials platform and changing the paradigm for patient care and clinical trial access globally. Read more: https://lnkd.in/enaTjx9j

Today Florida Cancer Specialists & Research Institute announced a groundbreaking partnership with Paradigm. We’re so proud to support their work. This collaboration will be a big step forward in expanding patient access to clinical trials across Florida. For patients and providers at FCS's extensive network of 33 early and late-phase research locations, Paradigm's powerful technology platform will streamline the planning, recruitment, and conduct of trials. Our work together will make it easier for more patients to have access to important treatment options, and for providers to focus on direct patient care rather than administration. For biopharma trial sponsors, this means the ability to bring trials directly to patients across Florida, and recruit diverse patients to assure the representatives of your trials. We’re grateful for the trust of Florida Cancer Specialists, and honored to help serve their patients. From Florida to Japan to North Dakota and beyond, we’re building an end-to-end new clinical trials platform and changing the paradigm for patient care. https://lnkd.in/eGMD5B_m